Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
BACKGROUND: Fixed-dose combination scored dispersible stavudine, lamivudine, and nevirapine minitablets (Triomune Baby and Junior; Cipla Ltd) are simpler and cheaper than liquid formulations and have correct dose ratios for human immunodeficiency virus-infected children. However, they cannot be used...
Asıl Yazarlar: | Mulenga, V, Cook, A, Walker, A, Kabamba, D, Chijoka, C, Ferrier, A, Kalengo, C, Kityo, C, Kankasa, C, Burger, D, Thomason, M, Chintu, C, Gibb, D |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2010
|
Benzer Materyaller
-
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
Yazar:: Fillekes, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
Yazar:: Fillekes, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
Yazar:: L'homme, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
Yazar:: Burger, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
Yazar:: Oudijk, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)